Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 -0.21%83 Cash-to-Debt is 0.27 as of Mar. 2026, which is 13% below its 10-year median of 0.31. GuruFocus rates BSP:MATD3 with a GF Score™ of 83/100 and a GF Value™ of R$5.93 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 70.45% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hospital Mater Dei's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.27.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Hospital Mater Deicouldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Hospital Mater Dei's Cash-to-Debt or its related term are showing as below:
BSP:MATD3'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 0.31 Max: 2.06
Current: 0.27
During the past 9 years, Hospital Mater Dei's highest Cash to Debt Ratio was 2.06. The lowest was 0.11. And the median was 0.31.
BSP:MATD3's Cash-to-Debt is ranked worse than 70.45% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 0.79
vs BSP:MATD3: 0.27
Hospital Mater Dei (BSP:MATD3) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Hospital Mater Dei Cash-to-Debt Related Terms
Hospital Mater Dei Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BSP:MATD3 vs HCA, THC, DVA: Cash-to-Debt Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a Cash-to-Debt of 0.27 as of Mar. 2026. This is 13% below median its historical median of 0.31. Over the past decade, Hospital Mater Dei's Cash-to-Debt has ranged from 0.11 to 2.06. According to the industry distribution chart, Hospital Mater Dei ranks #472 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 70.4%.
Is Hospital Mater Dei's Cash-to-Debt too high?
Hospital Mater Dei's current Cash-to-Debt of 0.27 is 13% below median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 2.06. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. Hospital Mater Dei's value of 0.27 is 65.8% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #472 out of 670 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #472 out of 670 companies for Cash-to-Debt. This places Hospital Mater Dei in the lower half of its industry. The industry median Cash-to-Debt is 0.79. Hospital Mater Dei's value of 0.27 is 65.8% below this benchmark. Historically, Hospital Mater Dei's own Cash-to-Debt has ranged from 0.11 to 2.06 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 0.79, Hospital Mater Dei has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Cash-to-Debt of 0.27 is 65.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Cash-to-Debt is 0.27, which is 13% below median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.93, compared to a current price of R$4.79 — trading 19.2% below its estimated fair value. The current Cash-to-Debt is 0.27, which is 13% below median its 10-year median of 0.31 and 65.8% below the Healthcare Providers & Services industry median of 0.79. Hospital Mater Dei's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Cash-to-Debt is 0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.79 is trading 19.2% below its estimated GF Value™ of R$5.93.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Cash-to-Debt: 0.27 (13% below median its 10-year median of 0.31)
GF Value™: R$5.93 vs. price of R$4.79 (19.2% below fair value)
Industry Position: 65.8% below the Healthcare Providers & Services median (#472 of 670)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
83GF Score
Get the complete analysis for BSP:MATD3
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
